Literature DB >> 8737452

Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ischemia in rats.

Y G Zhang1, T P Liu.   

Abstract

AIM: To study the influences of ginsenosides Rb1 and Rg1 (active components of the total saponins of Panax ginseng) on the brains against ischemia-reperfusion injury.
METHODS: Rat focal cerebral ischemia was induced by reversible middle cerebral artery occlusion (MCAO) without craniectomy. The influences of ginsenoside Rb1 and Rg1 on infarct size (IS), neurologic deficit (ND) and the contents of calcium and potassium in the infarct were observed.
RESULTS: In a 2-h ischemia, Rb1 10-40 mg.kg-1 i.v. 30 min before MCAO decreased IS by 20%-49% and ND score from 5.1 to 4.1-2.3, and inhibited Ca accumulation and K loss by 22%-50% and 18-37%, respectively; Rb1 10-40 mg.kg-1 i.v. immediately after MCA was recanalized decreased IS by 12%-35% and ND score from 5.2 to 4.3-3.3, and inhibited Ca accumulation and K loss by 10%-40% and 17%-30%, respectively. In permanent ischemia, Rb1 40 mg.kg-1 i.v. reduced IS, ND, Ca accumulation and K loss. However, Rg1 40 mg.kg-1 i.v. did not show effect on both permanent and 2-h MCAO.
CONCLUSIONS: Rb1 protected brain from ischemic and reperfusion injuries.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737452

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  8 in total

Review 1.  Active ingredients in Chinese medicines promoting blood circulation as Na+/K+ -ATPase inhibitors.

Authors:  Ronald J Y Chen; Tzyy-rong Jinn; Yi-ching Chen; Tse-yu Chung; Wei-hung Yang; Jason T C Tzen
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

2.  Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity.

Authors:  Ronald J Y Chen; Tse-yu Chung; Feng-yin Li; Nan-hei Lin; Jason T C Tzen
Journal:  Acta Pharmacol Sin       Date:  2008-12-08       Impact factor: 6.150

3.  Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study.

Authors:  Andrew Scholey; Anastasia Ossoukhova; Lauren Owen; Alvin Ibarra; Andrew Pipingas; Kan He; Marc Roller; Con Stough
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

Review 4.  Ginseng: a promising neuroprotective strategy in stroke.

Authors:  Vaibhav Rastogi; Juan Santiago-Moreno; Sylvain Doré
Journal:  Front Cell Neurosci       Date:  2015-01-20       Impact factor: 5.505

Review 5.  Efficacy and Mechanism of Panax Ginseng in Experimental Stroke.

Authors:  Lei Liu; Gigi A Anderson; Tyler G Fernandez; Sylvain Doré
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

6.  A 12-week, randomized, double-blind study to evaluate the efficacy and safety of liver function after using fermented ginseng powder (GBCK25).

Authors:  Su-Jin Jung; Ji-Hyun Hwang; Soo-Hyun Park; Eun-Kyung Choi; Ki-Chan Ha; Hyang-Im Baek; Dong-Gue Shin; Jeong-Hun Seo; Soo-Wan Chae
Journal:  Food Nutr Res       Date:  2020-04-06       Impact factor: 3.894

7.  A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.

Authors:  Hee Jin Kim; Pitna Kim; Chan Young Shin
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

8.  The neuroprotective effect of methanol extract of gagamjungjihwan and fructus euodiae on ischemia-induced neuronal and cognitive impairment in the rat.

Authors:  Bombi Lee; Eu-Jung Choi; Eun-Jung Lee; Seung-Moo Han; Dae-Hyun Hahm; Hye-Jung Lee; Insop Shim
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.